Skip to main content
. 2018 Oct 5;11:6555–6567. doi: 10.2147/OTT.S170836

Table 1.

Characteristics of the studies included in the meta-analysis

Author Date of publication Data of collection Number of patients Study period % Child– Pugh A % of patients with >1 nodule % liver etiology (HBV; HCV; alcohol; metabolic; other) Follow-up The Newcastle– Ottawa scale (NOS); total score
Lee et al9 2014 Retrospective study 162 2006–2007 84.6 10.5 (72.9; 21.6; 3.7; NR; NR) Mean 50.3 ± 19.9 8
El-Fattah et al10 2016 SEER registries 1,981 2004–2012 NR 26.2 NR Median 20; range 9–38 7
Zhang et al11 2017 Retrospective study 410 2005–2016 97.7 NR NR NR 7
Kao et al12 2017 Retrospective study 622 2002–2013 86.5 19.1 (47.7; 43.2; NR; NR; 9.1) Median 35.7 9
Cho et al13 2016 Retrospective study 438 2006–2009 85.9 NR (72.4; 16.2; 3.9; NR; 6.4) Median 68.4 8
Kang et al14 2017 Retrospective study 572 2006–2012 81.8 NR (63.6; 14.4; NR; NR; 10.5) Median 57.9 8
Lin et al15 2015 Retrospective study 70 2009–2011 85.7 46.9 (45.7; 44.3; NR; NR; NR) Median 20.7 ± 10.3 9
Yang et al16 2016 Retrospective study 316 2000–2013 77 21.6 (86.6; 10.2; 1.9; NR; 1.3) Mean 20.4 9
Dohi et al17 2016 Retrospective study 357 2001–2013 84 31.4 (12.1; 81.4; NR; NR; NR) NR 8
Gao et al18 2015 Retrospective study 184 2005–2013 51 NR (87; 9; NR; NR; 2) Median 65 9
Montasser et al20 2014 Retrospective study 105 2007–2011 NR 28.6 (2.8; 94.2; NR; NR; 1.9) Mean 20.1 ± 10.67 8
Facciorusso et al21 2014 Not indicated 103 2005–2010 83.4 NR (22.3; 60.1; NR; NR; 17.6) NR 7
Dan et al22 2013 Retrospective study 178 2005–2008 83.9 NR (89.2; NR; NR; NR; NR) Median 52.7 8
Lee et al23 2014 Retrospective study 161 2006–2007 86.9 22.6 (72; 19; NR; NR; 6) Mean 45 ± 21 8
Moribata et al24 2012 Retrospective study 97 2001–2006 63.6 NR (NR; 88.6; NR; NR; NR) NR 7
Lu et al25 2012 Not indicated 661 2004–2006 NR NR (NR; NR; NR; NR; NR) Median 41.9 8
Kao et al26 2012 Retrospective study 313 2002–2009 87.5 16 (44.7; 47.2; NR; NR; NR) Median 26.7 ± 19.1 7
Chen et al27 2012 Retrospective study 158 2003–2010 84.8 19.7 (36; NR; NR; NR; NR) Mean 34 8
Giorgio et al28 2011 Not indicated 143 2005–2010 50 NR (42.9; 57; NR; NR; NR) Mean 37 8
Goto et al29 2011 Retrospective study 69 2000–2007 78.2 NR (23.1; NR; NR; NR; NR) Median 17 9
Chen et al30 2011 Retrospective study 135 2003–2009 NR 16.8 (34.3; 56.3; NR; NR; NR) Mean 32.2 8
Rossi et al31 2011 Retrospective study 706 1998–2008 76.2 21.7 (4.5; 85.9; 4.2; NR; 2.4) Median 29 7
Takahashi et al32 2010 Retrospective study 461 2000–2007 77 37 (5.4; 85.2; NR; NR; NR) NR 7
Imai et al33 2010 Not indicated 24 2006–2007 83.3 NR (NR; NR; NR; NR; NR) Mean 12.3 7
dal Bello et al34 2010 Retrospective study 207 2000–2008 91.8 20.3 (NR; NR; NR; NR; NR) Median 36 7
N’Kontchou et al35 2009 Retrospective study 235 2001–2007 85 22 (7; 50; 37; NR; 4) Mean 27 8
Chinnaratha et al36 2015 Retrospective study 539 2006–2012 73 NR (18.3; 33.3; 15.1; 8.7; NR) Mean 13.5 8
Kao et al37 2012 Retrospective study 258 NR 87.6 19.5 (42.9; 47.6; NR; NR; NR) Median 28.5 8
Lencioni et al38 2003 Prospective study 102 NR 87 23 (12; 42; 15; NR; 6) Mean 22.9 9
Kao et al39 2011 Retrospective study 190 2002–2007 84.2 20 (47.6; 45.7; NR; NR; NR) Median 30.7 8
Tajiri et al40 2016 Retrospective study 163 2003–2014 79.1 NR (15.9; 68; NR; NR; NR) NR 7
Oh et al41 2017 Retrospective study 368 2007–2012 100 NR (78; NR; NR; NR; NR) Median 61 8
Lo et al42 2017 Retrospective study 152 2007–2015 78.3 NR (53.3; 30.9; NR; NR; NR) Median 10 8

Abbreviations: HBV, hepatitis B virus; HCV, hepatitis C virus; NR, not reported; SEER, Surveillance, Epidemiology, and End Results.